CSPC Pharmaceutical Group... (CHJTF)

PNK: CHJTF · Real-Time Price · USD

0.64

0.02 (3.23%)

At close: May 01, 2025, 8:00 PM

CSPC Pharmaceutical Income Statement

Financials in HKD. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	49.91B	40.47B	41.06B	52.13B	61.1B	53.05B	52.43B	47.72B	44.61B	40.19B	38.98B	35.61B	28.06B	19.76B	18.85B	17.86B	16.47B	15.08B	13.7B	12.79B	12.33B	11.87B	11.41B	10.69B	10.31B
Cost of Revenue	14.3B	11.86B	12.02B	14.95B	16.8B	14.26B	13.27B	11.67B	10.99B	10.18B	10.52B	10.19B	8.61B	6.28B	6.29B	6.27B	5.98B	5.7B	5.41B	5.33B	5.41B	5.49B	5.57B	5.36B	5.3B
Gross Profit	35.61B	28.61B	29.04B	37.18B	44.3B	38.78B	39.16B	36.05B	33.62B	30.01B	28.46B	25.41B	19.45B	13.48B	12.55B	11.59B	10.49B	9.39B	8.28B	7.46B	6.92B	6.38B	5.84B	5.33B	5.01B
Operating Income	11.61B	9.38B	9.31B	11.56B	13.45B	11.7B	11.71B	10.86B	9.85B	8.55B	7.83B	7.26B	5.83B	4.23B	4.09B	3.96B	3.67B	3.39B	3.1B	2.86B	2.73B	2.6B	2.47B	2.24B	2.09B
Interest Income	287.08M	287.08M	302.79M	421.7M	411.55M	411.55M	339.91M	308.39M	206.58M	116.57M	29.18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	11.96B	9.65B	9.96B	12.52B	14.45B	12.67B	12.71B	12.19B	11.57B	9.69B	8.42B	7.45B	5.93B	4.22B	4.05B	3.88B	3.61B	3.35B	3.08B	2.85B	2.71B	2.58B	2.45B	2.21B	2.06B
Net Income	9.45B	7.63B	8B	10.06B	11.59B	10.17B	10.33B	10.01B	9.48B	7.85B	6.77B	6.02B	4.77B	3.4B	3.26B	3.12B	2.9B	2.69B	2.47B	2.28B	2.17B	2.06B	1.95B	1.77B	1.65B
Selling & General & Admin	16.25B	13.18B	14.05B	18.83B	22.99B	20.24B	21.04B	19.41B	18.59B	17.03B	16.76B	15.08B	11.46B	7.91B	7.33B	6.67B	5.95B	5.23B	4.5B	4.03B	3.72B	3.41B	3.1B	2.83B	2.67B
Research & Development	8.13B	6.41B	6.04B	6.94B	7.84B	6.84B	6.41B	5.78B	5.18B	4.43B	3.87B	3.17B	2.34B	1.6B	1.45B	1.2B	852.1M	504.48M	156.87M	77.53M	77.53M	77.53M	77.53M	n/a	n/a
Other Expenses	349.16M	365.8M	735.96M	599.02M	388.58M	371.94M	n/a	n/a	n/a	n/a	n/a	-2.83B	-4.95B	-7.07B	-6.36B	-6.36B	-5.1B	-3.85B	-2.59B	-2.59B	-2.38B	-2.17B	-1.96B	-2.47B	-2.34B
Operating Expenses	24.36B	19.59B	20.09B	25.83B	30.85B	27.08B	27.45B	25.19B	23.78B	21.46B	20.63B	10.75B	4.18B	-2.23B	-2.26B	-1.49B	-1.3B	-1.11B	-924.51M	-335.92M	-434.8M	-533.68M	-632.57M	356.03M	332.02M
Interest Expense	21.47M	25.9M	33.9M	39.48M	36.68M	32.25M	20.97M	16.87M	19.51M	19.91M	43.37M	45.35M	58.43M	46.56M	57.68M	57.68M	44.01M	30.35M	16.69M	5.78M	9.55M	13.32M	17.1M	39.8M	42.26M
Selling & Marketing Expenses	11.79B	9.14B	9.26B	7.13B	4.71B	2.22B	n/a	n/a	n/a	n/a	n/a	3.97B	5.58B	7.19B	6.62B	5.97B	5.28B	4.58B	3.89B	3.46B	3.17B	2.88B	2.59B	2.35B	2.2B
Cost & Expenses	38.66B	31.45B	32.11B	40.77B	47.65B	41.34B	40.72B	36.86B	34.76B	31.64B	31.15B	23.74B	17.63B	10.94B	10.19B	10.94B	9.82B	8.7B	7.58B	8.09B	7.76B	7.44B	7.11B	8.46B	8.21B
Income Tax Expense	2.21B	1.71B	1.7B	2.2B	2.62B	2.31B	2.23B	2.08B	1.97B	1.8B	1.64B	1.46B	1.15B	827.11M	795.58M	754.28M	705.75M	657.23M	608.7M	567.89M	541.61M	515.34M	489.06M	441.15M	414.8M
Shares Outstanding (Basic)	11.84B	11.85B	n/a	11.89B	11.92B	11.93B	11.92B	11.95B	11.95B	11.95B	11.95B	11.95B	11.97B	11.96B	11.99B	11.98B	11.98B	11.77B	11.64B	11.62B	11.7B	11.59B	11.54B	11.46B	11.53B
Shares Outstanding (Diluted)	11.84B	11.85B	n/a	11.89B	11.92B	11.93B	11.92B	11.95B	11.96B	11.95B	11.96B	11.95B	11.97B	11.96B	11.99B	11.98B	11.98B	11.98B	11.64B	11.7B	11.7B	11.7B	11.54B	11.53B	11.53B
EPS (Basic)	0.81	0.66	0.69	0.99	0.97	0.85	0.87	0.84	0.79	0.65	0.56	0.50	0.40	0.28	0.27	0.26	0.25	0.23	0.21	0.20	0.19	0.18	0.17	0.15	0.14
EPS (Diluted)	0.81	0.66	0.69	0.99	0.97	0.85	0.87	0.84	0.79	0.65	0.56	0.50	0.40	0.28	0.27	0.26	0.25	0.23	0.21	0.20	0.19	0.18	0.17	0.15	0.14
EBITDA	12.84B	10.05B	9.99B	12.82B	15.23B	13.44B	13.33B	12.45B	11.34B	9.92B	9.04B	9.41B	9.11B	7.29B	7.08B	6.94B	6.37B	6.07B	4.78B	4.55B	3.29B	3.14B	3.65B	3.41B	4.06B
EBIT	7.67B	3.7B	3.9B	5.86B	7.83B	7.83B	9.55B	11.06B	9.99B	8.71B	7.82B	7.03B	6.78B	4.2B	4.04B	4.04B	3.51B	3.51B	2.34B	2.34B	1.24B	1.24B	1.67B	1.67B	2.17B
Depreciation & Amortization	1.82B	1.27B	1.27B	1.85B	1.78B	1.74B	1.62B	1.52B	1.42B	1.3B	1.21B	801.5M	571.18M	344.78M	335.69M	351.49M	337.36M	323.23M	309.1M	303.62M	285.5M	267.38M	249.26M	521.4M	516.54M